GSK Cidra Manufacturing FDA-483 Reports Cite Ariflo, 12 Other Products
Executive Summary
GlaxoSmithKline's pending chronic obstructive pulmonary disease therapy Ariflo (cilomilast) is among a dozen products manufactured in Cidra, Puerto Rico cited in recent FDA "Form 483" reports
You may also be interested in...
Alcon To Try Glaxo’s Ariflo For Dry Eye
Swiss firm builds pipeline with help from GSK and Origenis in latest eye care in-licensing deals.
Avandaryl Approval On Track Despite Consent Decree, GSK Says
GlaxoSmithKline is confident FDA will approve its diabetes line extension agent Avandaryl on schedule despite the fact that the manufacturing facility for the product is operating under a GMP consent decree
Avandaryl Approval On Track Despite Consent Decree, GSK Says
GlaxoSmithKline is confident FDA will approve its diabetes line extension agent Avandaryl on schedule despite the fact that the manufacturing facility for the product is operating under a GMP consent decree